Concert Pharmaceuticals Inc
NASDAQ:CNCE
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CNCE's stock price target?
Not Available
CNCE doesn't have any price targets made by Wall Street professionals.
What is Concert Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
32%
For the last 8 years the compound annual growth rate for Concert Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 4 years is 32%.